Etodolac for lowering rheumatoid factor

Details Etodolac for lowering rheumatoid factor Etodolac for lowering rheumatoid factor

1987-06-03

1988-05-03

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3140

Patent

active

047420766

ABSTRACT:
A method is disclosed for lowering rheumatoid factor blood levels by administering an effective amount of etodolac.

REFERENCES:
patent: 4533551 (1985-08-01), Martel
patent: 4670462 (1987-06-01), Hatz et al.
patent: 4677132 (1987-06-01), Hayward
Chem. Abst. 101-222257g (1984).
J. S. Goodwin et al, "Administration of Nonsteroidal Anti-Inflammatory Agents in Patients With Rheumatoid Arthritis", JAMA, vol. 250, No. 16, pp. 2485-2488 (1983).
Forre, O. et al, Non-Steroidal Anti-Inflammatory Drugs in Rheumatoid Arthritis" Inflammation, Supplement to vol. 8, 1984.
Pope, R. M. et al, "Differential Effects of Therapeutic Regiments on Specific Classes of Rheumatoid Factor", Ann. Rheum. Dis. 1986; 45; 183-189.

Affiliated with

Also associated with

Rating

Etodolac for lowering rheumatoid factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Etodolac for lowering rheumatoid factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Etodolac for lowering rheumatoid factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1506537